Amber Cooper
Reproductive Endocrinology Saint Louis, MO Medical Doctor
NPI 1871632364 CMS profile 130795
3023 N Ballas Rd, Ste 450 Bldg D, Saint Louis, MO 63131
General payments
$78,945
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Amber Cooper of Saint Louis, MO is reported in the CMS Open Payments database as having received $78,945 across 124 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Reproductive Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $11,044 | 16 | |
| 2024 | General | $5,875 | 11 | |
| 2023 | General | $24,350 | 16 | |
| 2022 | General | $15,070 | 22 | |
| 2021 | General | $9,522 | 22 | |
| 2020 | General | $4,578 | 8 | |
| 2019 | General | $8,508 | 29 |
Beside peers
- Amber Cooper
- Reproductive Endocrinology median
- Middle half of Reproductive Endocrinology
- National median
In program year 2025, general payments to Amber Cooper were reported at $11,044. Among 986 Reproductive Endocrinology profiles paid that year, the median was $141 and the middle half received between $66 and $285.
Show as a table
| Year | Amber Cooper | Reproductive Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,508 | $196 | $77–$425 | $163 |
| 2020 | $4,578 | $81 | $35–$182 | $114 |
| 2021 | $9,522 | $102 | $43–$247 | $132 |
| 2022 | $15,070 | $139 | $62–$303 | $149 |
| 2023 | $24,350 | $141 | $65–$285 | $160 |
| 2024 | $5,875 | $144 | $65–$302 | $164 |
| 2025 | $11,044 | $141 | $66–$285 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
124 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Reproductive Endocrinology in Missouri
Dan Lebovic
Reproductive Endocrinology · Saint Louis, MO
Molina Dayal
Reproductive Endocrinology · St. Louis, MO
Christina Boots
Reproductive Endocrinology · Saint Louis, MO
Kenan Omurtag
Reproductive Endocrinology · Saint Louis, MO
MacKenzie Purdy
Reproductive Endocrinology · Creve Coeur, MO
Peter Ahlering
Reproductive Endocrinology · Saint Louis, MO
Related records
Reproductive Endocrinology in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Reproductive Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.